Dose Escalation Study of MLN4924 in Adults With Melanoma
Clinical trial NCT01011530 · COMPLETED
Trial details
- NCT number
- NCT01011530
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.